BMJ Best Practice

参考文献

关键文献

Batlle D, Moorthi KM, Schluter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006;26:471-478.

Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2178-2184.

Haque SK, Ariceta G, Battle G. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012;27:4273-4287.

Sebastian A, Schambelan M, Lindenfeld S, et al. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med. 1977;297:576-583.

Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981;304:373-380.

Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592.

参考文章

1.  Batlle D, Moorthi KM, Schluter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006;26:471-478.

2.  Morris RC Jr. Renal tubular acidosis. Mechanisms, classification and implications. N Engl J Med. 1969;281:1405-1413.

3.  Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160-2170.

4.  Foreman JW. Fanconi syndrome and other proximal tubule disorders. In: Fehally J, Floege J, Johnson RJ eds. Comprehensive clinical nephrology. 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007:561-572.

5.  Igarashi T, Sekine T, Inatomi J, et al. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2171-2177.

6.  Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002;13:2178-2184.

7.  Schwarz C, Benesch T, Kodras K, et al. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant. 2006;21:2615-2620.

8.  Kocyigit I, Unal A, Kavuncuoglu F, et al. Renal tubular acidosis in renal transplantation recipients. Ren Fail. 2010;32:687-690.

9.  Online Mendelian Inheritance in Man (OMIM). Fanconi renotubular syndrome 1; FRTS 1: gene map locus 15q15.3. January 2011. http://www.ncbi.nlm.nih.gov/ (last accessed 22 September 2017).

10.  Haque SK, Ariceta G, Battle G. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012;27:4273-4287.

11.  Karet FE, Finberg KE, Nelson RD, et al: Mutations in the gene encoding the B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet. 1999;21:84-90.

12.  Karet FE, Gainza FJ, Gyory AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A. 1998;14:6337-6342.

13.  Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997;100:1693-1707.

14.  Smith AN, Skaug J, Choate KA, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000;26:71-75.

15.  Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570-1580.

16.  Caruana RJ, Buckalew VM Jr. The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltimore). 1988;67:84-99.

17.  Mason AM, Golding PL. Renal tubular acidosis and autoimmune thyroid disease. Lancet. 1970;2:1104-1107.

18.  Batlle D, Gaviria M, Grupp M, et al. Distal nephron function in patients receiving chronic lithium therapy. Kidney Int. 1982;21:477-485.

19.  Cohen EP, Bastani B, Cohen MR, et al. Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992;3:264-271.

20.  DeFranco PE, Haragasim L, Schmitz PG, et al. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjogren's syndrome. J Am Soc Nephrol. 1995;6:295-301.

21.  Sebastian A, Schambelan M, Lindenfeld S, et al. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med. 1977;297:576-583.

22.  Sebastian A, Schambelan M, Sutton JM. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol. 1984;4:287-300.

23.  Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981;304:373-380.

24.  DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980;17:118-134.

25.  Batlle DC. Hyperkalemic hyperchloremic metabolic acidosis associated with selective aldosterone deficiency and distal renal tubular acidosis. Semin Nephrol. 1981;1:260-273.

26.  Batlle D, Itsarayoungyen K, Arruda JA, et al. Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J Med. 1982;72:188-192.

27.  Batlle DC, Mozes MF, Manaligod J, et al. The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation. Am J Med. 1981;70:786-796.

28.  Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217-221.

29.  Higashihara E, Nutahara K, Tago K, et al. Medullary sponge kidney and renal acidification defect. Kidney Int. 1984;25:453-459.

30.  Morris RC, Yamauchi H, Palubinskas AJ, et al. Medullary sponge kidney. Am J Med. 1965;38:883-892.

31.  Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet. 1999;23:264-266.

32.  Bernarado AA, Bernardo CM, Espiritu DJ, et al. The sodium bicarbonate cotransporter: structure, function, and regulation. Semin Nephrol. 2006;26:352-360.

33.  Sly WS, Hewett-Emmett D, Whyte MP, et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A. 1983;80:2752-2756.

34.  Sly WS, Whyte MP, Sundaram V, et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med. 1985;313:139-145.

35.  Bridoux F, Kyndt X, Abou-Ayache R, et al. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases. Clin Nephrol. 2004;61:434-439.

36.  Izzedine H, Launay-Vacher V, Isnard-Bagnis C, et al. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003;41:292-309.

37.  Morimoto T, Uchida S, Sakamoto H, et al. Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria. J Am Soc Nephrol. 1998;9:811-818.

38.  Klootwijk ED, Reichold M, Helip-Wooley A, et al. Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med. 2014;370:129-138.

39.  Steinman B, Gitzelmann R, Van den Berghe G. Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:1489-1520.

40.  Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351:585-592.

41.  Sastrasinh S, Tannen RL. Effect of potassium on renal NH3 production. Am J Physiol. 1983;244:F383-F391.

42.  Steinmetz PR, Lawson LR. Defect in acidification induced in vitro by amphotericin B. J Clin Invest. 1970;49:596-601.

43.  McCurdy DK, Frederic M, Elkinton JR. Renal tubular acidosis due to amphotericin B. N Engl J Med. 1968;278:124-130.

44.  Patterson RM, Ackerman GL. Renal tubular acidosis due to amphotericin B nephrotoxicity. Arch Intern Med. 1971;127:241-244.

45.  Lowe M. Structure and function of the Lowe syndrome protein OCRL1. Traffic. 2005;6:711-719.

46.  Choudhury R, Diao A, Zhang F, et al. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell. 2005;16:3467-3479.

47.  Lu M, Holliday LS, Zhang L, et al. Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J Biol Chem. 2001;276:30407-30413.

48.  Park MA, Pejovic V, Kerisit KG, et al. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase C delta. J Am Soc Nephrol. 2006;17:3167-3175.

49.  Gahl, WA, Thoene JG, Schneider JA. Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:5085-5108.

50.  Sokol RJ, Twedt D, McKim JM, et al. Oxidant injury to hepatic mitochondria in patients with Wilson’s disease and Bedlington terriers with copper toxicosis. Gastroenterology. 1994;107:1788-1798.

51.  Morgan HG, Stewart WK, Lowe KG, et al. Wilson's disease and the Fanconi syndrome. Q J Med. 1962;31:361-384.

52.  Cuthbert JA. Wilson’s disease: a new gene and an animal model for an old disease. J Invest Med. 1995;43:323-326.

53.  Nissim I, Horyn O, Daikhin Y, et al. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res. 2006;66:7824-7831.

54.  Thirakomen K, Kozlov N, Arruda JA, et al. Renal hydrogen ion secretion after release of unilateral ureteral obstruction. Am J Physiol. 1976;231:1233-1239.

55.  Hanley MJ, Davidson K. Isolated nephron segments from rabbit models of obstructive nephropathy. J Clin Invest. 1982;69:165-174.

56.  Sabatini S, Kurtzman NA. Enzyme activity in obstructive uropathy: basis for salt wastage and the acidification defect. Kidney Int. 1990;37:79-84.

57.  Preminger GM, Sakhaee K, Skurla C, et al. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol. 1985;134:20-23.

58.  Buckalew VM Jr, Purvis ML, Shulman MG, et al. Hereditary renal tubular acidosis. Report of a 64 member kindred with variable clinical expression including idiopathic hypercalciuria. Medicine (Baltimore). 1974;53:229-254.

59.  Coe FL, Parks JH. Stone disease in heredity distal renal tubular acidosis. Ann Intern Med. 1980;93:60-61.

60.  Lee DB, Drinkard JP, Rosen VJ, et al. The adult Fanconi syndrome: observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine (Baltimore). 1972;51:107-138.

61.  Wegienka LC, Weller JM. Renal tubular acidosis caused by degraded tetracycline. Arch Intern Med. 1964;114:232-235.

62.  Russo JC, Adelman RD. Gentamicin-induced Fanconi syndrome. J Pediatr. 1980;96:151-153.

63.  Chisolm JJ Jr, Harrison HC, Eberlein WR, et al. Amino-aciduria, hypophosphatemia, and rickets in lead poisoning; study of a case. AMA Am J Dis Child. 1955;89:159-168.

64.  Morris RC Jr. The clinical spectrum of Fanconi's syndrome. Calif Med. 1968;1108:225.

65.  Hall PW III, Piscator M, Vasiljevic M, et al. Renal function studies on individuals with the tubular proteinuria of endemic Balkan nephropathy. Q J Med. 1972;41:385-393.

66.  Morris RC Jr. An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis; its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest. 1968;47:1648-1663.

67.  Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:1553-1587.

68.  Chen YT. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:1521-1551.

69.  Spencer AG, Franglen GT. Gross amino-aciduria following a Lysol burn. Lancet. 1952:1:190-192.

70.  Roth KS, Carter BE, Higgins ES. Succinylacetone effects on renal tubular phosphate metabolism: a model for experimental renal Fanconi syndrome. Proc Soc Exp Biol Med. 1991;196:428-431.

71.  Goyer RA, Krall A, Kimball JP. The renal tubule in lead poisoning: II. In vitro studies of mitochondrial structure and function. Lab Invest. 1968;19:78-83.

72.  Nordberg GF, Jin T, Nordberg M. Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis. Environ Health Perspect. 1994;102(Suppl 3):191-194.

73.  Adams RG, Harrison JF, Scott P. The development of cadmium-induced proteinuria, impaired renal function, and osteomalacia in alkaline battery workers. Q J Med. 1969;38:425-443.

74.  Ho PT, Zimmerman K, Wexler LH, et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995;76:2557-2564.

75.  Dubourg L, Michoudet C, Cochat P, et al. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide J Am Soc Nephrol. 2001;12:1615-1623.

76.  Vittecoq D, Dumitrescu L, Beaufils H, et al. Fanconi syndrome associated with cidofovir therapy [letter]. Antimicrob Agents Chemother. 1997;41:1846.

77.  Rifkin BS, Perazella MA. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. Am J Med. 2004;117:282-284.

78.  Kamel DS, Ethier JH, Quaggin S, et al. Studies to determine the basis of hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol. 1991;2:1279-1284.

79.  O'Kelly R, Magee F, McKenna TJ. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab. 1983;56:108-112.

80.  Batlle DC. Segmental characterization of defects in collecting tubule acidification. Kidney Int. 1986;30:546-554.

81.  Roscoe JM, Goldstein MB, Halperin ML, et al: Lithium-induced impairment of urine acidification. Kidney Int. 1976;9:344-350.

82.  Gabow PA, Moore S, Schrier RW. Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med. 1979;90:338-340.

83.  Kleyman TR, Roberts C, Ling BN. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med. 1995;122:103-106.

84.  Tan SY, Shapiro R, Franco R, et al. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med. 1979;90:783-785.

85.  Choi MJ, Fernandez PC, Patnaik A, et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med. 1993;328:703-706.

86.  Seldin DW, Portwood RM, Rector FC Jr, et al. Characteristics of renal bicarbonate reabsorption in man. J Clin Invest. 1959;38:1663-1671.

87.  Maldonado JE, Velosa JA, Kyle RA, et al. Fanconi syndrome in adults: a manifestation of a latent form of myeloma. Am J Med. 1975;58:354-364.

88.  Rochman J, Lichtig C, Osterweill D, et al. Adult Fanconi's syndrome with renal tubular acidosis in association with renal amyloidosis: occurrence in a patient with chronic lymphocytic leukemia. Arch Intern Med. 1980;140:1361-1363.

89.  Wilson DM, Goldstein NP. Bicarbonate excretion in Wilson's disease (hepatolenticular degeneration). Mayo Clin Proc. 1974;49:394-400.

90.  Ahya SN, Jose Soler M, Levitsky J, et al. Acid-base and potassium disorders in liver disease. Semin Nephrol. 2006;26:466-470.

91.  Caruana RJ, Barish CF, Buckalew VM Jr. Complete distal tubular acidosis in systemic lupus: clinical and laboratory findings. Am J Kidney Dis. 1985;6:59-63.

92.  Jaeger P, Portman L, Wauters JP, et al. Distal renal tubular acidosis and lymphocytic thyroiditis with spontaneously resolving hyperthyroidism. Am J Nephrol. 1985;5:116-120.

93.  Kaitwatcharachai C, Vasuvattakul S, Yenchitsomanus P, et al. Distal renal tubular acidosis and high urine carbon dioxide tension in a patient with southeast Asian ovalocytosis. Am J Kidney Dis. 1999;33:1147-1152.

94.  Vasuvattakul S, Yenchitsomanus PT, Vachuanichsanong P, et al. Autosomal recessive distal renal tubular acidosis associated with Southeast Asian ovalocytosis. Kidney Int. 1999;56:1674-1682.

95.  Tosukhowong P, Tungsanga K, Eiam-Ong S, et al. Environmental distal renal tubular acidosis in Thailand: an enigma. Am J Kidney Dis.1999;33:1180-1186.

96.  Lowe MB, Tapp E. Renal damage caused by anhydro-4-EPI-tetracycline. Arch Pathol. 1996;81:362-364.

97.  Vaziri ND, Ness RL, Farishter RD, et al. Nephrotoxicity of paraquat in man. Arch Intern Med. 1979;139:172-174.

98.  Moss AH, Gabow PH, Kaehny WD, et al. Fanconi’s syndrome and distal renal tubular acidosis after glue sniffing. Ann Intern Med. 1980;92:69-70.

99.  Tatu CA, Orem WH, Finkelman RB, et al. The etiology of Balkan endemic nephropathy: still more questions than answers. Environ Health Perspect. 1998;106:689-700.

100.  Stefanovic V, Plenakovic M. Fifty years of research in Balkan endemic nephropathy: where are we now? Nephron Clin Pract. 2009;112:c51-c56.

101.  Ng JL, Morgan DJR, Loh NK, et al. Life-threatening hypokalemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011;194:313-316.

102.  Lambert AP, Close C. Life-threatening hypokalaemia from abuse of Nurofen plus. J Royal Soc Med. 2005;98:21.

103.  Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009;49(suppl 5):S185-S195.

104.  Oduwole AO, Giwa OS, Arogundade RA. Relationship between rickets and incomplete distal renal tubular acidosis in children. Ital J Pediatr. 2010;36:54.

105.  Mul D, Grote FK, Goudriaan JR, et al. Should blood gas analysis be part of the diagnostic workup of short children? Auxological data and blood gas analysis in children with renal tubular acidosis. Horm Res Paediatr. 2010;74:351-357.

106.  Batlle DC, Hizon M, Cohen E, et al. The use of urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med. 1988;318:594-599.

107.  Oh MS, Carroll HJ. Value and determinants of urine anion gap. Nephron. 2002;90:252-255.

108.  Laski ME, Kurtzman NA. Evaluation of acid-base disorders from the urine. In: Seldin DW and Giebisch G, eds. The regulation of acid-base balance. New York, NY: Raven Press; 1989:265-283.

109.  Vallo A, Rodriguez-Soriano J. Oral phosphate-loading test for the assessment of distal urinary acidification in children. Miner Electrolyte Metab. 1984;10:387-390.

110.  Halperin ML, Goldstein MB, Haig A, et al. Studies on the pathogenesis of type 1 (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions. J Clin Invest. 1974;53:669-677.

111.  Stinebaugh BJ, Shloeder FX, Gharafry E, et al. Mechanism by which neutral phosphate infusion elevates urine PCO2. J Lab Clin Med. 1977;89:946-958.

112.  Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977;56:38-54.

113.  Wrong O, Davies W. The excretion of acid in renal disease. Q J Med. 1959;23:259.

114.  Walsh SB, Shirley DG, Wrong OM, et al. Urinary acidification assessed by simultaneous furosemide and fludrocortisones treatment: an alternative to ammonium chloride. Kidney Int. 2007;71:1310-1316.

115.  Alon U, Hellerstein S. Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol. 1994;8:250-251.

116.  Brodehl J. Fanconi syndrome. In: Davison AM, Cameron JS, Grunfeld JP, et al, eds. Oxford textbook of clinical nephrology. 2nd ed. New York, NY: Oxford University Press; 1998:1019-1037.

117.  Domrongkitchaiporn S, Khositseth S, Stitchantrakul W, et al. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients. Am J Kidney Dis. 2002;39:383-391.

118.  Rodriguez-Soriano J, Vallo A, Castillo G, et al. Natural history of primary distal renal tubular acidosis treated since infancy. J Pediatr. 1982;101:669-676.

119.  McSherry E, Morris RC Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest. 1978;61:509-527.

使用此内容应接受我们的免责声明。